Key result
Elevated NHHR is not significantly linked to hypertension after adjusting for BMI.
Why the study?
Dyslipidemia is a known contributor to hypertension, but the utility of the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) for hypertension assessment remains unclear.
Is an elevated non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) independently associated with an increased prevalence of hypertension in adults?
Cross-Sectional (n=10,735)
No
Is an elevated non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) independently associated with an increased prevalence of hypertension in adults?
Relative Risk: 1.03 (95% CI 1–1.07)
p-value: p=0.068
An elevated NHHR is associated with hypertension, but this relationship is largely explained by adiposity (BMI), suggesting limited independent clinical utility for hypertension screening.
NHHR may support hypertension risk assessment in adults; leaves open its added value beyond standard lipids in prospective studies.
Background Dyslipidemia is a known contributor to hypertension, yet the utility of the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) for hypertension assessment remains unclear. We examined whether the NHHR is associated with hypertension and whether this association varies by demographic and metabolic characteristics. Methods This cross-sectional study included 10,735 adults who underwent health examinations. Participants were grouped by NHHR quartiles. Modified Poisson regression was used to estimate prevalence ratios (PRs) for the association between NHHR and hypertension. Results Hypertension was present in 32.8% of participants. Each one-unit increase in NHHR was not significantly associated with hypertension in the unadjusted model (PR 0.99, 95% CI 0.96–1.03, P = 0.735). After adjustment for age, sex, and eGFR, the association became significant (PR 1.09, 95% CI 1.05–1.12, P < 0.001), with participants in the highest quartile having 24% higher prevalence compared with the lowest (PR 1.24, 95% CI 1.13–1.37, P < 0.001). However, after additional adjustment for BMI, the association was substantially attenuated (PR 1.03, 95% CI 1.00–1.07, P = 0.068). These findings were robust across sensitivity analyses. Conclusions An elevated NHHR was associated with hypertension after adjustment for demographic factors, but this association was substantially attenuated by BMI, suggesting that adiposity largely accounts for the observed relationship. The NHHR may serve as a convenient lipid-related marker, but its clinical utility for screening requires further investigation.
No takes yet. Share an insight, caveat, or question.
Hong et al. (2026) conducted a cross-sectional in Hypertension (n=10,735). Non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) vs. Lower NHHR was evaluated on Prevalence of hypertension (PR 1.03, 95% CI 1.00-1.07, p=0.068). An elevated NHHR was initially associated with a higher prevalence of hypertension, but this association was substantially attenuated and no longer significant after adjusting for BMI (PR 1.03).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: